Abstract:To develop a new interventional oncology technique, "radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus thymidine kinase (GFP/HSV-TK)/ganciclovir (GCV) gene therapy of cholangiocarcinoma." Luciferase/mCherry-labeled cholangiocarcinoma cells and 24 mice with subcutaneously implanted cholangiocarcinoma cells were treated by: (i) a combination of green fluorescent protein (GFP)/HSV-TK/plasmid gene transfection followed by RFH and ganciclovir exposure; (ii) gene therapy alone; (iii) RFH alone; and (iv) phosphate-buffered saline (PBS) to serve as a control (6 mice per group). Cell viabilities were quantified by MTS assay. Bioluminescent optical imaging and transcutaneous ultrasound imaging were used to follow up the tumor growth over 2 weeks. For in-vivo technical validation of the new technique, pigs in two groups received either intrabiliary delivery of GFP/HSV-TK/plasmid using a needle-integrated balloon catheter flowed by RFH enhancement (n = 6) or gene delivery only (n = 6). GFP signal in bile duct walls were quantified by optical imaging.The non- parametric Mann-Whitney U test was used for statistical comparison of variables. MTS assay demonstrated the lowest cell proliferation in combination therapy compared with three control groups (24.0 ± 5.3% vs 41.9 ± 6.4% vs 72.0 ± 9.0% vs 100%, p<0.001). GFP optical imaging confirmed that GFP/HSV-TK gene expression peaked at day 2 after gene transfection. Bioluminescent optical imaging demonstrated the decreased bioluminescence signals in tumors of combination therapy, compared with other control groups (0.71 ± 0.16 vs 1.46 ± 0.21 vs 2.10 ± 0.27 vs 2.36 ± 0.28, p<0.001). Ultrasound imaging showed the smallest tumor volumes of the combination therapy group, compared with other groups (0.90 ± 0.21 VS 1.61 ± 0.21 VS 2.22 ± 0.25 VS 2.50 ± 0.30, p<0.001). optical imaging confirmed higher GFP expression in the bile ducts with RFH enhancement (signal to noise ratio: 1.28 ± 0.61 VS 0.49 ± 0.31, P<0.05). It is feasible to use intratumoral RFH to enhance GFP/HSV-TK/plasmid gene expression and HSV-TK/GCV gene therapy of cholangiocarcinomas.This concept may pave a new avenue for managing pancreatobiliary malignancies.(supported by an NIH RO1EBO12467)

Target gene transfer mediated by electroporation for cancer therapy in vivo

Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells

&Lt;p>echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System</p>

Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus

Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System.

Intrabiliary Radiofrequency Heating-Enhanced Direct Intratumoral GFP/HSV-TK Gene Therapy of Cholangiocarcinoma: A Preclinical Study on Mice and Pigs

Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy – spatial and time dependent distribution

Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy.

Tumor-directed Gene Therapy in Mice Using a Composite Nonviral Gene Delivery System Consisting of the Piggybac Transposon and Polyethylenimine

Controlled Delivery of Plasmid DNA to Melanoma Tumors by Gene Electrotransfer

Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread

Expression of GFP and DsRed fluorescent proteins after gene electrotransfer of tumour cells in vitro

Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.

Progress of in vivo Gene Transfer with Electroporation

Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors

Enhanced Antitumor Effect of EGF R–targeted P21waf-1 and GM-CSF Gene Transfer in the Established Murine Hepatoma by Peritumoral Injection

Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

A novel receptor-targeted gene delivery system for cancer gene therapy

Plasmid DNA gene therapy by electroporation: principles and recent advances.

Gene Delivery Using a Receptor-Mediated Gene Transfer System Targeted to Hepatocellular Carcinoma Cells.

Tumor gene therapy by systemic delivery of plasmid DNA with cell‐penetrating peptides